✦ LIBER ✦

The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: Results of a comparative analysis

✍ Scribed by Molica, Stefano; Giannarelli, Diana; Gentile, Massimo; Cutrona, Giovanna; Di Renzo, Nicola; Di Raimondo, Francesco; Neri, Antonino; Federico, Massimo; Ferrarini, Manlio; Morabito, Fortunato

Book ID: 122574001
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 457 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Large genomic aberrations detected by SN

Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH

✍ Mian, M.; Rinaldi, A.; Mensah, A. A.; Rossi, D.; Ladetto, M.; Forconi, F.; Maras 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 491 KB

A shorter time to the first treatment ma

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia

✍ Giovanni D'Arena; Fiorella D'Auria; Vittorio Simeon; Luca Laurenti; Silvia Deagl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

A prognostic algorithm including a modif

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)

✍ Molica, Stefano; Giannarelli, Diana; Levato, Luciano; Mirabelli, Rosanna; Gentil 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 748 KB

Chronic myelogenous leukemia in nonlymph

Chronic myelogenous leukemia in nonlymphoid blastic phase : Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

✍ Stefano Sacchi; Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Mary Beth Rios 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## BACKGROUND. The prognoses of patients with chronic myelogenous leukemia in blastic phase (CML-BP) are extremely poor. Treatment of patients with nonlymphoid CML-BP is associated with very low response rates, a median survival of 2-3 months, and significant toxicities. The aim of this study was